Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal vs Intravenous Dexmedetomidine in Elective Cesarean Section
NCT06410365Phase 4Not yet recruiting
- Start
- Jun 2024
- Primary completion
- Oct 2024
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial of dexmedetomidine in pain and Nausea and Vomiting (2 arms). Primary endpoints: Intraoperative Nausea and Vomiting, Intraoperative Shivering and 1 more. Planned start Jun 2024; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
painNausea and Vomiting
Beyond the preview
Go deeper on NCT06410365.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06410365.